FAM53C Activators
FAM53C Activators encompass a class of compounds that influence cellular signaling pathways and processes to enhance the functional activity of FAM53C. These compounds operate through various mechanisms to indirectly influence the activity of FAM53C within its native cellular context. Forskolin, for instance, activates adenylyl cyclase, causing an increase in cAMP levels that can activate PKA. PKA can phosphorylate a breadth of proteins, including those that modify the activity of FAM53C. Similarly, Genistein, by inhibiting specific tyrosine kinases, may alter signaling pathways, leading to the indirect enhancement of FAM53C activity.
PD 98059, SB203580, SP600125, and U0126 modulate key signaling pathways like PI3K/AKT, MAPK/ERK, p38 MAPK, and JNK, respectively. Inhibition of these kinases leads to cellular responses that could activate compensatory pathways, possibly enhancing FAM53C's functional activity. Rapamycin's inhibition of mTOR may also induce feedback mechanisms that can enhance FAM53C activity. Ionomycin's role in increasing intracellular calcium levels could stimulate calcium-dependent signaling pathways, leading to the enhanced activity of FAM53C. PMA's activation of PKC and Gö 6983's inhibition of PKC suggest that modulation of PKC signaling could indirectly affect pathways that enhance the activity of FAM53C. Lastly, KN-93's inhibition of CaMKII might influence calcium signaling, which could in turn enhance the functional activity of FAM53C through downstream signaling changes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is an inhibitor of tyrosine kinases. By inhibiting certain tyrosine kinases, it can lead to a compensatory activation of alternative pathways that may include kinases or phosphatases that regulate FAM53C activity, leading to its functional enhancement. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits MEK, which is involved in the MAPK/ERK pathway. This inhibition can cause a compensatory response in other signaling pathways that may enhance the functional activity of FAM53C through indirect effects on signaling dynamics. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which could result in the activation of compensatory pathways that indirectly enhance the functional activity of FAM53C. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, possibly leading to the activation of calcium-dependent signaling pathways that enhance the activity of FAM53C. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate a range of proteins. If FAM53C is influenced by PKC signaling pathways, PMA can indirectly enhance its activity. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Gö 6983 is a broad-spectrum PKC inhibitor that can disrupt PKC signaling, potentially leading to the activation of alternative pathways which might enhance FAM53C activity if it is linked to these pathways. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93 is an inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII). Inhibition of CaMKII can lead to changes in calcium signaling, potentially affecting signaling pathways that enhance the functional activity of FAM53C. | ||||||